tiprankstipranks
Trending News
More News >
Capstone Therapeutics Corp (CAPS)
:CAPS
US Market

Capstone Therapeutics (CAPS) Ratios

Compare
23 Followers

Capstone Therapeutics Ratios

CAPS's free cash flow for Q4 2024 was $0.20. For the 2024 fiscal year, CAPS's free cash flow was decreased by $ and operating cash flow was $-0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.02 1.14 1.76 1.66 1.45
Quick Ratio
0.25 0.28 0.30 0.47 0.46
Cash Ratio
<0.01 <0.01 <0.01 <0.01 0.00
Solvency Ratio
-0.05 -0.15 0.08 0.14 0.42
Operating Cash Flow Ratio
0.30 0.10 -0.24 0.41 0.06
Short-Term Operating Cash Flow Coverage
0.43 0.13 -0.35 0.65 0.10
Net Current Asset Value
$ -37.48M$ -6.50M$ -10.91M$ -16.50M$ -9.74M
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.39 0.44 0.47 0.38
Debt-to-Equity Ratio
-3.36 8.34 0.86 0.97 0.71
Debt-to-Capital Ratio
1.42 0.89 0.46 0.49 0.42
Long-Term Debt-to-Capital Ratio
-0.89 0.72 0.34 0.39 0.24
Financial Leverage Ratio
-15.44 21.63 1.96 2.09 1.89
Debt Service Coverage Ratio
-0.02 -0.16 0.37 0.68 1.56
Interest Coverage Ratio
-0.43 -0.82 4.46 4.38 3.37
Debt to Market Cap
29.14 21.11 8.67 35.31 11.66
Interest Debt Per Share
74.69 138.68 188.43 370.84 271.43
Net Debt to EBITDA
-16.11 -11.59 6.80 5.63 7.88
Profitability Margins
Gross Profit Margin
21.33%19.88%26.85%24.45%24.06%
EBIT Margin
-1.42%-4.25%6.49%6.95%5.27%
EBITDA Margin
-1.42%-3.62%6.88%7.52%5.81%
Operating Profit Margin
-1.42%-2.60%6.49%6.95%5.27%
Pretax Profit Margin
-13.23%-7.41%5.03%6.53%3.71%
Net Profit Margin
-5.71%-7.90%3.76%5.87%23.00%
Continuous Operations Profit Margin
-12.24%-7.90%3.76%5.87%22.38%
Net Income Per EBT
43.17%106.53%74.73%89.99%620.11%
EBT Per EBIT
930.56%285.43%77.59%93.98%70.37%
Return on Assets (ROA)
-5.43%-7.25%3.55%6.44%19.05%
Return on Equity (ROE)
83.81%-156.71%6.95%13.48%35.92%
Return on Capital Employed (ROCE)
-1.84%-3.33%7.49%8.97%5.47%
Return on Invested Capital (ROIC)
-1.36%-2.69%4.78%7.18%28.47%
Return on Tangible Assets
-10.73%-12.99%5.52%10.48%33.53%
Earnings Yield
-725.97%-465.97%79.40%573.11%775.76%
Efficiency Ratios
Receivables Turnover
16.25 18.73 20.31 16.88 11.21
Payables Turnover
10.69 13.36 16.52 19.03 10.11
Inventory Turnover
3.66 3.02 2.59 4.61 3.14
Fixed Asset Turnover
12.25 10.34 11.72 11.25 7.46
Asset Turnover
0.95 0.92 0.94 1.10 0.83
Working Capital Turnover Ratio
37.89 8.63 8.11 12.04 22.06
Cash Conversion Cycle
87.92 113.12 136.90 81.67 112.69
Days of Sales Outstanding
22.46 19.48 17.97 21.62 32.56
Days of Inventory Outstanding
99.61 120.95 141.02 79.23 116.22
Days of Payables Outstanding
34.16 27.31 22.10 19.18 36.09
Operating Cycle
122.07 140.43 158.99 100.85 148.78
Cash Flow Ratios
Operating Cash Flow Per Share
24.24 9.19 -18.34 46.97 8.10
Free Cash Flow Per Share
23.48 7.87 -19.43 32.18 8.06
CapEx Per Share
0.76 1.32 1.10 14.80 0.04
Free Cash Flow to Operating Cash Flow
0.97 0.86 1.06 0.69 1.00
Dividend Paid and CapEx Coverage Ratio
31.84 2.43 -16.71 0.73 214.00
Capital Expenditure Coverage Ratio
31.84 6.97 -16.71 3.17 214.00
Operating Cash Flow Coverage Ratio
0.37 0.07 -0.10 0.13 0.03
Operating Cash Flow to Sales Ratio
0.09 0.03 -0.05 0.06 0.01
Free Cash Flow Yield
1048.30%151.42%-105.05%372.87%47.41%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.14 -0.21 1.26 0.17 0.13
Price-to-Sales (P/S) Ratio
<0.01 0.02 0.05 0.01 0.03
Price-to-Book (P/B) Ratio
-0.12 0.34 0.09 0.02 0.05
Price-to-Free Cash Flow (P/FCF) Ratio
0.10 0.66 -0.95 0.27 2.11
Price-to-Operating Cash Flow Ratio
0.09 0.57 -1.01 0.18 2.10
Price-to-Earnings Growth (PEG) Ratio
0.03 <0.01 -0.02 >-0.01 >-0.01
Price-to-Fair Value
-0.12 0.34 0.09 0.02 0.05
Enterprise Value Multiple
-16.66 -12.05 7.49 5.77 8.39
EV to EBITDA
-16.66 -12.05 7.49 5.77 8.39
EV to Sales
0.24 0.44 0.51 0.43 0.49
EV to Free Cash Flow
2.87 17.00 -10.35 11.36 34.67
EV to Operating Cash Flow
2.78 14.56 -10.97 7.78 34.51
Tangible Book Value Per Share
-167.45 36.97 -84.16 -222.70 68.24
Shareholders’ Equity Per Share
-19.40 15.46 211.48 366.78 367.14
Tax and Other Ratios
Effective Tax Rate
0.07 -0.07 0.25 0.10 -5.03
Revenue Per Share
284.73 306.80 390.59 841.90 573.32
Net Income Per Share
-16.26 -24.23 14.69 49.46 131.88
Tax Burden
0.43 1.07 0.75 0.90 6.20
Interest Burden
9.31 1.74 0.78 0.94 0.70
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-1.49 -0.38 -1.25 0.95 0.08
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis